GB Sciences (GBS) (OTC:GBLX) is a research and biotechnical development company.
Business Model:
Revenue: $0
Employees: 51-200
Address:
City: Las Vegas
State: Nevada
Zip:
Country: United States
GB Sciences (GBS) (OTC:GBLX) is a research and biotechnical development company setting the gold standard for manufacturing medical cannabis producing technology, as well as discovering, developing, and commercializing proprietary strains of cannabis to treat a broad range of serious medical conditions.
Contact Phone:
Contact Email:
Listed Exchange:
OTCQB
IPO Date:
7/30/2004
Ticker Symbol:
GBLX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2014 | Post-IPO Equity | $2M | 1/2016 | Post-IPO Equity | $20k |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|